Financhill
Back

BCB Bancorp Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
21

BCBP
BCB Bancorp

Last Price:
9.91
Seasonality Move:
-1.94%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
21
BCB Bancorp (BCBP) is a Sell

Is BCB Bancorp a Buy, Sell or Hold?

  • The current BCB Bancorp [BCBP] share price is $9.91. The Score for BCBP is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • BCBP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCBP Stock Price Chart

What is BCB Bancorp's stock price today?

  • The BCB Bancorp share price today is $9.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCBP is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

BCBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 48.39 Sell
Chaikin Money Flow: -8889 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.76 - 10.22) Sell
Bollinger Bands (100): (9.68 - 10.82) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

BCBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.88 Buy
20-day SMA: 9.89 Buy
50-day SMA: 9.98 Sell
200-day SMA: 11 Sell
8-day EMA: 9.91 Sell
20-day EMA: 9.95 Sell
50-day EMA: 10.07 Sell
200-day EMA: 11.05 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

BCB Bancorp Earnings Growth & BCBP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.62 per share, and an increase next year of $0.30 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

BCB Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):